Core Scientific Statistics

Total Valuation

Core Scientific has a market cap or net worth of $3.64 billion. The enterprise value is $4.13 billion.

Market Cap	3.64B
Enterprise Value	4.13B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Core Scientific has 297.82 million shares outstanding. The number of shares has decreased by -19.45% in one year.

Current Share Class	297.82M
Shares Outstanding	297.82M
Shares Change (YoY)	-19.45%
Shares Change (QoQ)	+18.67%
Owned by Insiders (%)	1.46%
Owned by Institutions (%)	77.69%
Float	288.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.23
Forward PS	6.95
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.26

Current Ratio	4.26
Quick Ratio	3.58
Debt / Equity	n/a
Debt / EBITDA	324.50
Debt / FCF	n/a
Interest Coverage	-5.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-6.09%
Return on Invested Capital (ROIC)	-11.00%
Return on Capital Employed (ROCE)	-8.31%
Revenue Per Employee	$1.26M
Profits Per Employee	-$2.71M
Employee Count	325
Asset Turnover	0.34
Inventory Turnover	n/a

Taxes

In the past 12 months, Core Scientific has paid $858,000 in taxes.

Income Tax	858,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+36.12%
50-Day Moving Average	9.99
200-Day Moving Average	11.95
Relative Strength Index (RSI)	60.12
Average Volume (20 Days)	10,457,234

Short Selling Information

The latest short interest is 46.48 million, so 15.61% of the outstanding shares have been sold short.

Short Interest	46.48M
Short Previous Month	46.10M
Short % of Shares Out	15.61%
Short % of Float	16.14%
Short Ratio (days to cover)	3.83

Income Statement

In the last 12 months, Core Scientific had revenue of $410.91 million and -$879.79 million in losses. Loss per share was -$3.20.

Revenue	410.91M
Gross Profit	63.87M
Operating Income	-118.84M
Pretax Income	-830.24M
Net Income	-879.79M
EBITDA	-14.90M
EBIT	-118.84M
Loss Per Share	-$3.20

Full Income Statement

Balance Sheet

The company has $697.94 million in cash and $1.19 billion in debt, giving a net cash position of -$496.21 million or -$1.67 per share.

Cash & Cash Equivalents	697.94M
Total Debt	1.19B
Net Cash	-496.21M
Net Cash Per Share	-$1.67
Equity (Book Value)	-181.51M
Book Value Per Share	-0.61
Working Capital	637.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.88 million and capital expenditures -$151.49 million, giving a free cash flow of -$171.37 million.

Operating Cash Flow	-19.88M
Capital Expenditures	-151.49M
Free Cash Flow	-171.37M
FCF Per Share	-$0.58

Full Cash Flow Statement

Margins

Gross margin is 15.54%, with operating and profit margins of -28.92% and -229.98%.

Gross Margin	15.54%
Operating Margin	-28.92%
Pretax Margin	-229.77%
Profit Margin	-229.98%
EBITDA Margin	-3.63%
EBIT Margin	-28.92%
FCF Margin	n/a

Dividends & Yields

Core Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	19.45%
Shareholder Yield	19.45%
Earnings Yield	-24.19%
FCF Yield	-4.71%

Analyst Forecast

The average price target for Core Scientific is $18.69, which is 53.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.69
Price Target Difference	53.07%
Analyst Consensus	Strong Buy
Analyst Count	17
Revenue Growth Forecast (5Y)	33.83%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Core Scientific has an Altman Z-Score of -1.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.36
Piotroski F-Score	2